Wisdom Cultural Tourism
-
"Demon child" Nezha: How he captured the hearts of global viewersDetails
BEIJING,Feb. 21,2025-- A news report fromChina.org.cn on the Chinese blockbuster "Ne Zha 2":
-
NetEase Cloud Music and Starship Entertainment Forge Copyright Partnership to Deliver Premium K-pop Content to Chinese AudiencesDetails
HANGZHOU,China,Feb. 23,2025-- Korean entertainment group Starship Entertainment has entered into a copyright partnership with China\'s premier online music platform,NetEase Cloud Music. This agreement
-
Leading the AI Chart: Cisco Engage Greater Bay Area 2025 Focuses on the Next Wave of Transformation TechnologiesDetails
News Summary: New innovations showcase the company\'s leading portfolio designed to help customers build,secure and operate AI-ready data centers.
-
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, HanoiDetails
HANOI,Vietnam,Feb. 24,2025--Vantage Foundation proudly announces its partnership with National Burn Hospital LeHuu Trac in Hanoi,a leading medical facility specialising in burn treatments & rehab
-
Dongying's investment soars with quality focusDetails
DONGYING,China,Feb. 21,2025-- A news report from chinadaily.com.cn: Dongying\'s investment promotion system has made significant strides in 2024 by enhancing the quality and efficiency of investment a
-
NaaS Technology Inc. Announces US$10 Million Share Repurchase ProgramDetails
BEIJING,Feb. 21,2025-- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company in China,today announced that its board of di
-
VVDN and Red Hat Collaborate to Deliver Cutting-Edge RAN Intelligent Controller (RIC) Solution on Red Hat OpenShiftDetails
GURUGRAM,India,Feb. 24,2025-- VVDN Technologies,a global provider of software,product engineering,and electronics manufacturing services and solutions,collaborates with Red Hat Inc.,the world\'s lead
-
NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon CancerDetails
SAN FRANCISCO andSUZHOU,China,Feb. 24,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua
-
Over 3.2 million likes! Witsbb's Australia Traceability Livestream Witnesses Quality Commitment, Allergen-Free Nutrition Gains Global AttentionDetails
SYDNEY,Feb. 23,2025-- After travelling over ten hours by plane,Chinese well-knownblogger @Guo Xiaopang Couple reached Sydney,Australia,and started Witsbb\'s traceability livestream,revealing the secre
-
Fangzhou Inc. Announces Inclusion as a Constituent of the Hang Seng Composite IndexDetails
HONG KONG,Feb. 24,2025-- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK),a leader in Internet healthcare solutions,announced today that the Company has been selected and wi